Wednesday, February 10, 2010, 6:19pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

MDRNA, Inc. (MRNA)

At 4:59AM SGT: 0.8949 USD   0.00 (0.00%)  
 MORE ON MRNA 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 MDRNA, Inc. (NGM:MRNA) Delayed quote dataEdit
Last Trade:0.8949 USD
Trade Time:4:59AM SGT
Change: 0.00 (0.00%)
Prev Close:0.8949
Open:N/A
Bid:0.83 x 200
Ask:1.07 x 300
1y Target Est:3.00
Day's Range:N/A - N/A
52wk Range:0.22 - 3.55
Volume:0
Avg Vol (3m):1,451,510
Market Cap:36.48M
P/E (ttm):N/A
EPS (ttm):-0.558
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add MRNA to Portfolio   Download Data

 HEADLINES 
•MDRNA, Inc. Reports Positive Results for Its Proprietary siRNA Delivery Technology
Marketwire (Mon, Feb 8)
•MDRNA, Inc. Receives Compliance Extension From NASDAQ
Marketwire (Mon, Feb 8)
•MDRNA, Inc. to Present at the 12th Annual BIO CEO & Investor Conference
Marketwire (Mon, Feb 1)
•Sirius XM, Tellabs: Early Volume Plays
at TheStreet.com (Tue, Jan 26)
•MDRNA, Inc. Issued Patent for the Use of Nucleic Acids to Treat Cancer
Marketwire (Tue, Jan 26)
•MDRNA, Inc. Announces Allowance of European Patent Covering Formulations for Rapid Acting Insulin
Marketwire (Thu, Jan 21)
•This Drugmaker Will Rally by Summer: Investors
at CNBC (Wed, Jan 20)
•MDRNA Draws Bullish Options Trade
at TheStreet.com (Wed, Jan 20)
•Ballard Power, Enterra: Early Volume Plays
at TheStreet.com (Tue, Jan 19)
•MDRNA Demonstrates Significantly Reduced Off-Target Activity for Proprietary RNAi-Based Compounds
Marketwire (Tue, Jan 19)
More Headlines for MRNA...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.38
EPS Est (in 2 years) (Dec-10) :-0.33
Avg Rec (current)*:2.5
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
MDRNA, Inc. operates as a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi).

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices